Last reviewed · How we verify

NCT06950762

Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial

Not yet recruiting NA Last updated 18 June 2025
What this trial tests

NA trial testing Giomer based injectable composite in Restoration of Carious Class v Anterior Teeth in 50 participants. Not yet recruiting.

Timeline
10 June 2025
Primary endpoint
13 April 2026
13 April 2026

Quick facts

Lead sponsorFuture University in Egypt
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date10 June 2025
Primary completion13 April 2026
Estimated completion13 April 2026

Drugs / interventions tested

Conditions studied

Sponsor

Future University in Egypt

Who can join

Adults 20 to 60, any sex, with Restoration of Carious Class v Anterior Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using bioactive injectable resin composite in anterior class v carious lesions can provide better aesthetic outcome and marginal integrity by releasing multiple ions, including fluoride. This offers better marginal integrity due to presence of S-PRG fillers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Future University in Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06950762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing